Stocks and securities in focus
| Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Actinium Pharmaceuticals Inc. | -1.960% | 11.214% | -2.177% | -10.125% | 59.071% | 12.344% | - |
| Biogen Inc. | 1.040% | 11.703% | 1.104% | -27.082% | -14.589% | -9.463% | -0.983% |
| Cardiff Oncology Inc. | -3.130% | 4.220% | -17.343% | 159.554% | 209.650% | -48.418% | 16.429% |
| Cyclacel Pharmaceuticals Inc. | -2.260% | - | - | - | - | - | - |
| Eli Lilly Corp. | 6.680% | 5.213% | 1.693% | 103.868% | 38.769% | 382.039% | 603.978% |
| ImmunityBio Inc. | -9.860% | 46.091% | 49.480% | 194.252% | 58.347% | -49.404% | - |
| Viking Therapeutics Inc | 6.230% | 22.841% | -1.714% | 285.618% | 326.308% | 1301.128% | - |
| X4 Pharmaceuticals, Inc. | 1.550% | -7.860% | -15.600% | -22.426% | 35.256% | - | - |